Viral Immunology, Vaccines, and Antivirals
A section of Viruses (ISSN 1999-4915).
Section Information
- acquired resistance and evolution
- regulatory/societal/legislation aspects
- immune system stimulation
- limitations of vaccines
- new developments and the future
- natural antivirals and their uses
- viral infections
- differences between antivirals and antibiotics in health care
- antiviral use in children
- immunology/animal models
- adverse effects
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Gamma Delta T Cells in Immune Response against Viruses (Deadline: 15 September 2021)
- Viral Strategies of Immune Evasion (Deadline: 30 September 2021)
- Cross-Reactivity in Virus Infection (Deadline: 30 September 2021)
- Viral Immune Modulation (Deadline: 30 September 2021)
- Vaccines and Therapeutics against Emerging Viruses (Deadline: 1 October 2021)
- Advances in Antiviral Immunity and Virus Vaccines (Deadline: 15 October 2021)
- Host Cell-Virus Interaction (Deadline: 31 October 2021)
- Memories of, Anecdotes about, and Thoughts on Two Pioneers of the Complement Field —Sir Peter J. Lachmann, 1931–2020 and Robert B. Sim, 1951–2021 (Deadline: 31 October 2021)
- Adverse Effects of Antiretroviral Therapy (Deadline: 30 November 2021)
- Antivirals for Newly Emerging Viral Diseases of Global Importance (Deadline: 30 November 2021)
- Viral Hepatitis Treatment (Deadline: 30 November 2021)
- Basic Studies for Vaccine Development Targeting Virus Infections (Deadline: 30 November 2021)
- HIV-1 Infection and Immunometabolism: Relevance to HIV Pathogenesis and Persistence (Deadline: 15 December 2021)
- Cytomegalovirus Immunity 2021 (Deadline: 15 December 2021)
- Toll-Like Receptors in Antiviral Immunity (Deadline: 31 December 2021)
- Adenovirus Cell and Immune Interactions (Deadline: 31 December 2021)
- Viral Evasion of Innate Immunity and Drug Development (Deadline: 31 December 2021)
- Correlates of Immune Protection Against HIV Infection (Deadline: 31 December 2021)
- Interaction between Virus and Host Innate Immune Systems (Deadline: 31 December 2021)
- Antibodies and B Cell Memory in Viral Immunity (Deadline: 31 December 2021)
- Ways to Eliminate Viral Hepatitis as a Global Health Threat (Deadline: 31 December 2021)
- Advances in Vaccines and Host-Targeted Therapeutics Against Respiratory Viruses (Deadline: 21 January 2022)
- Broad Spectrum Antivirals and Antiviral Combinations (Deadline: 31 January 2022)
- T Cells in Viral Infections (Deadline: 1 May 2022)
- Host Targeted Therapeutics against Virus Infections (Deadline: 31 May 2022)
- New Aspects of Adenoviral Vaccine Vectors and Adenoviral Gene Therapy (Deadline: 31 August 2022)